The Global Burden of Disease (GBD) study is the most comprehensive international epidemiologcal study to date, led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, USA. The forthcoming GBD 2020 will be the first study iteration to incorporate the population health impact of COVID-19.
In this webinar, Prof Dr Theo Vos will present initial insights on findings from the Global Burden of Disease 2020 study.
More information about the webinar is available via https://www.burden-eu.net/activities/webinars/619-webinar-initial-insights-from-the-global-burden-of-disease-2020-study.
